Herpesviruses
Herpesviruses: molecular monitoring and risk management in transplant patients
Explore solutions for herpesvirus diagnostics
The risk in transplant patients
Real-Time PCR techniques make it possible to detect viral DNA and, when provided for by the test, to quantify it in the samples analyzed. Monitoring over time can help to:
- identify the presence of viral DNA;
- follow the trend of the viral load;
- support risk assessment in transplant patients;
- provide useful information for clinical decisions and follow-up.
The frequency of testing and the interpretation of the results depend on the virus, the type of transplant and the patient’s condition.
Herpesviruses of particular interest in transplantation
Cytomegalovirus (CMV) is one of the main opportunistic infections in transplant patients. EBV also requires attention because of its association with post-transplant lymphoproliferative disorders (PTLD). HHV-6, HSV and VZV can cause significant clinical manifestations in immunocompromised patients. Nuclear Laser Medicine offers tests for the detection and, depending on the product, the quantification of various herpesviruses, to support the laboratory’s diagnostic activities.